Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
Status:
Recruiting
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
NODE-303 is a multi-center, open label (OL) study to evaluate the safety of etripamil NS in
patients with Paroxysmal Supraventricular Tachycardia (PSVT). Patients will be provided with
an ambulatory Cardiac Monitoring System (CMS) to help document PSVT episodes. The CMS will be
self-applied by the patient, when PSVT symptoms begin. Patients will self-administer
etripamil NS if vagal maneuver is ineffective. After an episode of PSVT where drug is
administered, the patient will return to the investigative site for a study visit and will be
given the option to continue in NODE-303 and manage subsequent episodes of PSVT with
etripamil NS.